Stocktoria

Arbutus Biopharma Corp ABUS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-11-13 · LEI

Arbutus Biopharma Corp statistics & valuation

Market cap$904.7M
P / S64.2×
P / B11.8×
Net margin-237.9%
Return on equity-43.7%
FCF margin-281.5%
Net cash$18.0M
Enterprise value USD$886.7M
Earnings yield EBIT/EV-4.3%
Return on capital-43.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-25765.50% -788.90% -959.80% -2557.40% -922.00% -693.90% -178.00% -401.60% -1133.00% -237.90% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-32973.80% -1036.70% -1510.20% -2394.00% -836.10% -669.10% -167.80% -430.50% -1236.70% -271.00% 2016201720182019202020212022202320242025
Return on equity (%)
-189.20% -46.30% -28.50% -211.30% -62.50% -45.00% -50.80% -68.70% -71.80% -43.70% 2016201720182019202020212022202320242025
Shares outstanding
54.8M 55.1M 55.5M 64.8M 89.7M 145.0M 157.5M 169.9M 190.0M 192.5M 2016201720182019202020212022202320242025
Net debt ($)
-$109.3M -$30.8M -$26.3M -$36.3M -$18.0M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-139.20% -35.60% -25.00% -145.70% -46.50% -37.30% -35.50% -50.40% -53.10% -35.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-4150.30% -522.50% -1160.70% -1191.10% -747.30% -622.00% -91.90% -479.30% -1053.80% -281.50% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.00× 0.00× 0.00× 0.00× 2016201720182019202020212022202320242025
EPS ($)
-$7.24 -$1.56 -$1.21 -$1.00 -$0.83 -$0.46 -$0.44 -$0.38 -$0.17 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-271.0%-1236.7%-430.5%-167.8%-669.1%-836.1%-2394.0%-1510.2%-1036.7%-32973.8%
Net margin-237.9%-1133.0%-401.6%-178.0%-693.9%-922.0%-2557.4%-959.8%-788.9%-25765.5%
FCF margin-281.5%-1053.8%-479.3%-91.9%-622.0%-747.3%-1191.1%-1160.7%-522.5%-4150.3%
Return on assets-35.4%-53.1%-50.4%-35.5%-37.3%-46.5%-145.7%-25.0%-35.6%-139.2%
Return on equity-43.7%-71.8%-68.7%-50.8%-45.0%-62.5%-211.3%-28.5%-46.3%-189.2%
Debt / equity0.00×0.00×0.00×0.00×0.00×—————
Current ratio15.738.155.874.6014.3213.3811.9911.508.8412.52

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.